2004
DOI: 10.1590/s0074-02762004000300001
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

5
253
1
65

Year Published

2008
2008
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 290 publications
(324 citation statements)
references
References 49 publications
5
253
1
65
Order By: Relevance
“…Finally, parasites of the subgenus Viannia, especially L. [V.] braziliensis, have been identified as the major etiologic agent of ICL. The histology of this picture normally shows a nodular infiltration of lymphocytes and plasma cells in the dermis, with rare macrophages and parasites (Table 1) [11,12].…”
Section: Cutaneous Leishmaniasismentioning
confidence: 99%
“…Finally, parasites of the subgenus Viannia, especially L. [V.] braziliensis, have been identified as the major etiologic agent of ICL. The histology of this picture normally shows a nodular infiltration of lymphocytes and plasma cells in the dermis, with rare macrophages and parasites (Table 1) [11,12].…”
Section: Cutaneous Leishmaniasismentioning
confidence: 99%
“…Approximately 200,000-400,000 new visceral leishmaniasis cases and 700,000-1,200,000 new cutaneous leishmaniasis cases occur each year worldwide (1). Leishmania amazonensis belongs to the Leishmania mexicana complex and causes localized cutaneous and diffuse cutaneous leishmaniasis (2). These parasites often hijack the host's innate immune response to establish a successful infection, particularly in macrophages.…”
mentioning
confidence: 99%
“…L. amazonensis infection leads to a spectrum of clinical presentations ranging from a single cutaneous lesion to diffuse cutaneous leishmaniasis, a clinical form that is usually refractory to treatment and is associated with the absence of Leishmania-antigen-specific cell-mediated immune responses (Convit et al 1993). There is evidence that L. amazonensis is able to suppress the potentially effective immune responses of the host (Silveira et al 2004) and that interleukin (IL)-10 contributes, at least in part, to the compromised parasite-specific immunity in L. amazonensisinfected hosts (Jones et al 2002, Ji et al 2003.…”
mentioning
confidence: 99%